Sign up to save your podcasts
Or
Share Long Term Efficacy and Safety of Dupilumab for Eosinophilic Esophagitis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Long Term Efficacy and Safety of Dupilumab for Eosinophilic Esophagitis
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Swathi Eluri, MD, MS discuss “Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial,” by Summarizing Rothenber M, Dellon E, Collins M, et al. Lancet Gastroenterol Hep. 2023; 9: 990-1004
View all episodes
By American College of Gastroenterology
4.7
1717 ratings
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Swathi Eluri, MD, MS discuss “Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial,” by Summarizing Rothenber M, Dellon E, Collins M, et al. Lancet Gastroenterol Hep. 2023; 9: 990-1004
More shows like Evidence-Based GI: An ACG Publication and Podcast
View all
JAMA Clinical Reviews
496 Listeners
American Journal of Gastroenterology Author Podcasts
69 Listeners
Gut Podcast
8 Listeners
White Coat Investor Podcast
2,442 Listeners
The Curbsiders Internal Medicine Podcast
3,340 Listeners
Core IM | Internal Medicine Podcast
1,153 Listeners
Annals On Call Podcast
195 Listeners
The Clinical Problem Solvers
511 Listeners
Run the List
248 Listeners
Behind the Case: An ACG Case Reports Journal Podcast
6 Listeners
The Daily Motivation
915 Listeners
Critical Care Time
231 Listeners
Gastroenterology Learning Network
13 Listeners
Listen In: GI Endoscopy
33 Listeners
Gastroenterology & Endoscopy
3 Listeners